Abbott Laboratories (ABL) Stock Price & News

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia

About Abbott Laboratories

CEORobert B. Ford

Employees115 миң

Founded1888

HeadquartersЧикаго, Иллинойс, Америка Кошмо Штаттары

SectorMedical device

Websiteabbott.com

All values in USD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	11,37 млд	11,46 млд	11,16 млд	12,59 млд
Cost of goods sold	5,08 млд	4,91 млд	4,89 млд	5,32 млд
Cost of revenue	5,08 млд	4,91 млд	4,89 млд	5,32 млд
Research and development expenses	766,00 млн	720,00 млн	767,00 млн	892,00 млн
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,90 млд	2,93 млд	3,58 млд	3,87 млд
Operating expense	4,09 млд	4,07 млд	4,77 млд	5,42 млд
Total operating expenses	9,16 млд	8,98 млд	9,66 млд	10,74 млд
Operating income	2,20 млд	2,48 млд	1,50 млд	1,85 млд
Other non operating income	2,00 млн	-15,00 млн	-	-25,00 млн
EBT including unusual items	2,18 млд	2,36 млд	1,45 млд	1,52 млд
EBT excluding unusual items	2,18 млд	2,44 млд	1,45 млд	1,52 млд
Income tax expense	536,00 млн	582,00 млн	372,00 млн	596,00 млн
Effective tax rate	24,59%	24,68%	25,67%	39,11%
Other operating expenses	-	-	-	-
Net income	1,64 млд	1,78 млд	1,08 млд	928,00 млн
Net profit margin	14,46%	15,50%	9,65%	7,37%
Earnings per share	1,30	1,50	1,15	1,31
Interest and investment income	77,00 млн	78,00 млн	106,00 млн	52,00 млн
Interest expense	-121,00 млн	-120,00 млн	-174,00 млн	-351,00 млн
Net interest expenses	-44,00 млн	-42,00 млн	-68,00 млн	-299,00 млн
Depreciation and amortization charges	-	-	-	-
EBITDA	3,00 млд	3,27 млд	2,31 млд	2,91 млд
Gain or loss from assets sale	-	65,00 млн	-	-

Ask anything